We are live on ! Find out more
MA

Minerva Advisors Portfolio holdings

AUM $155M
1-Year Est. Return 35.49%
This Fund
S&P 500
This Quarter Est. Return
+29.33%
1 Year Est. Return
+35.49%
3 Year Est. Return
+149.41%
5 Year Est. Return
+142.03%
10 Year Est. Return
+662.71%
AUM
$182M
AUM Growth
+$33.3M
Cap. Flow
-$5.34M
Cap. Flow %
-2.94%
Top 10 Hldgs %
61.56%
Holding
79
New
3
Increased
13
Reduced
19
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 33.85%
2 Financials 15.47%
3 Healthcare 13.67%
4 Materials 9.47%
5 Communication Services 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEHR icon
76
Aehr Test Systems
AEHR
$2.64B
-17,401
Closed -$24K
FTK icon
77
Flotek Industries
FTK
$839M
-7,004
Closed -$114K
SSY
78
DELISTED
SunLink Health Systems
SSY
-35,200
Closed -$33K
ALR
79
DELISTED
AlerisLife Inc
ALR
-14,417
Closed -$73K

Similar funds

Minerva Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Minerva Advisors held 79 positions worth $182M, up 22% from $148M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Minerva Advisors's Q4 2020 filing shows 3 new, 13 increased, 19 reduced and 4 closed positions. Its largest new stake was Telos: 41,725 shares worth $1.37M. The largest sale was InfuSystem Holdings, an estimated $4.49M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Minerva Advisors's largest Q4 2020 buy was Telos: 41,725 shares worth $1.37M.
  • Minerva Advisors added most to Astronics in Q4 2020, an estimated $2.3M increase.
  • Minerva Advisors's biggest Q4 2020 reduction was InfuSystem Holdings, cutting an estimated $4.49M.
  • Minerva Advisors fully exited Flotek Industries in Q4 2020, selling an estimated $114K.
  • Minerva Advisors's ten largest holdings make up 62% of its $182M portfolio in Q4 2020.
  • Minerva Advisors opened 3 new positions and closed 4 in Q4 2020.
  • Minerva Advisors's portfolio value rose 22% quarter-over-quarter to $182M.

Based on Minerva Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.